Literature DB >> 3238949

Persistent alanine aminotransferase elevation in healthy Swedish blood donors--mainly caused by obesity.

R Wejstål1, G Hansson, A Lindholm, G Norkrans.   

Abstract

Five hundred consecutive healthy blood donors were tested for serum alanine aminotransferase (ALT) and 44 (8.8%) had increased levels. Donors with and without raised ALT were compared in several aspects but only weight (expressed as percentage of ideal body weight) and sex differed significantly (119.1 +/- 14.5 and 106.3 +/- 12.8%, respectively; p less than 0.001 and males 97.7 and 77.1%, respectively; p less than 0.01). The 44 donors with raised ALT were followed up and in 13 out of 15 donors with persistently raised ALT without obvious reason, a liver biopsy was performed. Ten donors had various degrees of liver steatosis, 2 had normal liver morphology and in 1 donor chronic hepatitis could not be ruled out. If ALT screening is introduced as a surrogate test for non-A, non-B hepatitis in Swedish blood donors, we suggest that a correction for overweight must be considered in order to minimize donor loss.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3238949     DOI: 10.1111/j.1423-0410.1988.tb05083.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  5 in total

1.  Range of Normal Serum Aminotransferase Levels in Liver Transplant Recipients.

Authors:  Mohammad Bilal Siddiqui; Samarth Patel; Chandra Bhati; Trevor Reichman; Kenyada Williams; Carolyn Driscoll; Erika Liptrap; Mary E Rinella; Richard K Sterling; M Shadab Siddiqui
Journal:  Transplant Proc       Date:  2019 Jul - Aug       Impact factor: 1.066

2.  ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.

Authors:  Paul Y Kwo; Stanley M Cohen; Joseph K Lim
Journal:  Am J Gastroenterol       Date:  2016-12-20       Impact factor: 10.864

3.  Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans.

Authors:  Federica Sentinelli; Stefano Romeo; Cristina Maglio; Michela Incani; Maria A Burza; Francesca Scano; Federica Coccia; Efisio Cossu; Frida Leonetti; Marco G Baroni
Journal:  Lipids Health Dis       Date:  2011-06-10       Impact factor: 3.876

4.  Lowering the upper limit of serum alanine aminotransferase levels may reveal significant liver disease in the elderly.

Authors:  Hemda Schmilovitz-Weiss; Rachel Gingold-Belfer; Alon Grossman; Nidal Issa; Doron Boltin; Yichayaou Beloosesky; Nira Morag Koren; Joseph Meyerovitch; Avraham Weiss
Journal:  PLoS One       Date:  2019-04-11       Impact factor: 3.240

5.  Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter?

Authors:  Roberta Forlano; Benjamin H Mullish; Ameet Dhar; Robert D Goldin; Mark Thursz; Pinelopi Manousou
Journal:  World J Hepatol       Date:  2021-12-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.